Global Aortic Valve Replacement Devices Market Size study & Forecast, by Product Type (Transcatheter Aortic Valve, Sutureless Valve, Others) by Surgery (Open Surgery, Minimally Invasive Surgery), by End User (Hospitals, Ambulatory Surgical Centers, Others

Global Aortic Valve Replacement Devices Market Size study & Forecast, by Product Type (Transcatheter Aortic Valve, Sutureless Valve, Others) by Surgery (Open Surgery, Minimally Invasive Surgery), by End User (Hospitals, Ambulatory Surgical Centers, Others) and Regional Analysis, 2022-2029

Global Aortic Valve Replacement Devices Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Aortic valve replacement devices are medical devices used to replace a damaged or diseased aortic valve in the heart. There are several types of devices used for aortic valve replacement, including mechanical valves, sutureless valve, and transcatheter aortic valve replacement (TAVR) devices. The key factor driving the market growth is rising prevalence of cardiovascular disorders, growing geriatric population, and increasing preference for minimally invasive surgeries that anticipated to create the lucrative demand for the market during forecast period.

Moreover, the increased number of patients with cardiovascular problems is one of the primary factors boosting the demand for new aortic valves. Aortic valve malfunction is a result of cardiovascular diseases, which increases the need for an efficient valve replacement method. As aortic stenosis rates increase, transcatheter aortic valve replacement is becoming more popular. For instance, according to the research study published in December 2021, by Elsevier, for older people aged 45 and above, the overall self-reported prevalence of diagnosed cardiovascular diseases (CVDs) was 29.4%. The prevalence rate increased with age, from 22% in the 45–54 age group to 38% in the 70+ age group, showing that the senior population is at high risk of having CVDs. Also, according to the World Health Organization (WHO) report 2021, there were approximately 17.9 million deaths due to cardiovascular diseases in 2019, which shows nearly 32% of all deaths globally. In addition, as per the National Library of Medicine, India is recorded with the highest burden of cardiovascular disease (CVD) globally. The total number of deaths from CVD in India is estimated to grow from 2.26 million (1990) to 4.77 million (2020). Additionally, rising technological advancements aortic valve replacement devices and cohesive government initiative for creating awareness about valve replacement surgeries is anticipated to create the lucrative opportunity for the market during forecast period. However, the high cost of Aortic Valve Replacement Devices stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Aortic Valve Replacement Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of kay market players, rising prevalence of valvular disorders, growing geriatric population, and rising awareness regarding the benefits of TAVR over other surgical procedures in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising geriatric population and the rising prevalence of heart diseases. Moreover, the presence of a large target population, growing government investment in healthcare infrastructure would create lucrative growth prospects for the Aortic Valve Replacement Devices market across Asia Pacific region.

Major market player included in this report are:
Boston Scientific Corporation
Medtronic
Abbott Laboratories
LivoNova Plc.
Edwards Lifesciences Corporation
CryoLife Inc.
Blue Sail Medical Co. Ltd.
JC Medical Inc.
JenaValve Techologies Inc.
Meril Lifesciences

Recent Developments in the Market:
In April 2019, The LOTUS Edge Aortic Valve received US FDA approval by Boston Scientific Corporation. The only FDA-approved aortic valve that offers physicians the ability to reposition and fully recapture the valve after it has been fully deployed is the LOTUS Edge valve system.

Global Aortic Valve Replacement Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Surgery, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product Type:
Transcatheter Aortic Valve
Sutureless Valve
Others
By Surgery:
Open Surgery
Minimally Invasive Surgery
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Boston Scientific Corporation
Medtronic
Abbott Laboratories
LivoNova Plc.
Edwards Lifesciences Corporation
CryoLife Inc.
Blue Sail Medical Co. Ltd.
JC Medical Inc.
JenaValve Techologies Inc.
Meril Lifesciences

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.